VIRADAPT

VIRADAPT

AIDS A French study of AIDS Pts unresponsive to protease inhibitors. See Genotype testing.
Mentioned in ?
References in periodicals archive ?
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.
Drug-resistance genotyping in HIV 1 therapy: the VIRADAPT randomised controlled trial.
The VIRADAPT study was a prospective, open, randomized, and controlled study of individuals with HIV-1 infection for whom combination therapy failed (9).
Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study.
Patients not in the control arm exhibited substantial improvements after receiving treatment based on the results from genotyping using VIRADAPT.